1540 related articles for article (PubMed ID: 15771684)
1. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
2. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
3. [Combined infection with HTLV-1 and Strongyloides stercoralis].
Pays JF
Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
[TBL] [Abstract][Full Text] [Related]
4. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
6. Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Porto AF; Santos SB; Muniz AL; Basilio V; Rodrigues W; Neva FA; Dutra WO; Gollob KJ; Jacobson S; Carvalho EM
J Infect Dis; 2005 Feb; 191(4):612-8. PubMed ID: 15655786
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
[TBL] [Abstract][Full Text] [Related]
8. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
Freites A
Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
Courouble G; Rouet F; Herrmann-Storck C; Nicolas M; Candolfi E; Deloumeaux J; Carme B
West Indian Med J; 2004 Jan; 53(1):3-6. PubMed ID: 15114885
[TBL] [Abstract][Full Text] [Related]
10. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Porto AF; Neva FA; Bittencourt H; Lisboa W; Thompson R; Alcântara L; Carvalho EM
Parasite Immunol; 2001 Sep; 23(9):503-7. PubMed ID: 11589779
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological aspects of Strongyloides stercoralis infection in Okinawa, Japan.
Arakaki T; Kohakura M; Asato R; Ikeshiro T; Nakamura S; Iwanaga M
J Trop Med Hyg; 1992 Jun; 95(3):210-3. PubMed ID: 1597879
[TBL] [Abstract][Full Text] [Related]
13. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
Robinson RD; Lindo JF; Neva FA; Gam AA; Vogel P; Terry SI; Cooper ES
J Infect Dis; 1994 Mar; 169(3):692-6. PubMed ID: 8158055
[TBL] [Abstract][Full Text] [Related]
14. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
Foucan L; Genevier I; Lamaury I; Strobel M
Med Trop (Mars); 1997; 57(3):262-4. PubMed ID: 9513154
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
16. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
Arch EL; Schaefer JT; Dahiya A
Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
[TBL] [Abstract][Full Text] [Related]
18. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
Dixon AC; Yanagihara ET; Kwock DW; Nakamura JM
West J Med; 1989 Oct; 151(4):410-3. PubMed ID: 2588581
[TBL] [Abstract][Full Text] [Related]
19. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
[TBL] [Abstract][Full Text] [Related]
20. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
Einsiedel L; Fernandes L
Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
